‘Lets Talk About It’: South Australian Sexual Health Survey Results 2019

SAHMRI & Flinders University,  4th October, 2019

A South Australian-first youth sexual health survey has provided a unique snapshot of the sexual behaviours and knowledge of the state’s young people. 

The head of SAHMRI’s Sexual Health and Wellbeing program, Associate Professor James Ward, says the results will help design policies, health services and education programs aimed at reducing sexually transmitted infections (STIs), HIV and viral hepatitis (BBVs).

 

 

Women taking pill may be less likely to suffer ACL injury, study finds

The Guardian,

Clinical Education Forum Recording: Contraception Update

SHINE SA, November 2018

Clinicians:  SHINE SA is pleased to present the following Clinical Forum by Dr Amy Moten on the topic of Contraception.

This recording is available free of charge, and access is limited to three months only.

This forum covers emergency contraception and new formulations of the Pill.

3 Category 2 RACGP Points can be awarded on completion of the forum.

Recording length: 1 hour 18 minutes

New free MOOC from Adelaide Uni: Sex and Human Reproduction

University of Adelaide, June 2018

AdelaideX’s Massive Open Online Courses (MOOCs) offer learners free to study university-level online courses on a variety of topics.  AdelaideX’s latest MOOC, Sex and Human Reproduction, will launch on Thursday 12 July and enrolments are now open. 

Led by Professor Mario Ricci (Adelaide Medical School), and made in collaboration with experts from the Robinson Research Institute, this five-week course will cover all things related to sex and reproduction – from puberty to menopause, to fertility and contraception. The course focuses on underlying human biology, common myths, and the latest medical advances.

What you’ll learn

  • Structure and function of the male and female reproductive systems
  • Regulation of reproductive processes and cycles
  • Common reproductive disorders
  • Methods of contraception and assisted reproduction
  • Real world application of cutting-edge research in reproductive medicine

This MOOC is free (with a $50 fee for a verified certificate if desired).

 

 

Reproductive health of HIV-positive women being neglected, says Swiss study

nam/aidsmap, 06 February 2018

HIV-positive women in Switzerland are mainly relying on male condoms for contraception, investigators report in HIV Medicine. “Male condoms remained the most frequently used contraceptive method, whereas the use of long-acting reversible contraceptives was very uncommon,” note the researchers. “One in six women using contraceptives experienced an unwanted pregnancy, with 42% occurring while using a combined hormonal pill.

The investigators suggest that HIV clinicians need to do more to encourage effective contraceptive use by women with HIV, especially in the light of growing awareness that people with HIV with undetectable viral load do not transmit HIV. If couples stop using the male condom, women need information about which contraceptive options are suitable for them.

SHINE SA Media Release: Response to the call to ban Diane-35

SHINE SA, issued 13th December 2017

SHINE SA believes everyone should have access to contraceptive choices, and that decisions about contraception are best made in conjunction with a healthcare professional.

Cyproterone acetate pills, commonly known as Diane-35 appear to be associated with a higher risk of deep venous thrombosis (DVT) than levonorgestrel (LNG) containing pills, although the overall risk is still very low for most people.

For those who choose combined pills, we recommend as first choice the pills with lowest risk: those containing levonorgestrel or norethisterone as their progesterone. However, the other progestogen choices, which all carry a small increased risk of DVT compared to LNG, may be utilised if specific added benefits are required. Health professionals can review over time the experience individuals may have with their contraceptive choice.

Cyproterone acetate can be used as treatment for signs of androgenisation in people such as severe acne (involving inflammation or nodularity, or risk of scarring) where prolonged oral antibiotics or local treatment alone have not been successful, or idiopathic hirsutism of mild to moderate degree. The oral contraceptive pill containing cyproterone acetate can also provide effective oral contraception in this patient group.
People who have concerns should seek advice from their doctor before stopping their oral contraceptive pill.

Download Media release (PDF): Response to the call to ban Diane-35 SHINE SA Diane35_13 Dec 17_FS